-
Hypertension and Hypokalemia in a Patient Treated for Invasive Aspergillosis. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Damien Denimal
-
Fluctuating von Willebrand Factor Activity in a Young Adult. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Meredith G Parsons,Anna E Merrill
-
FDA's Final Rule on Laboratory Developed Tests. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Xander M R van Wijk,Stephen R Master,Jonathan R Genzen
-
Milky Urine in a Patient with Poorly Controlled Type 2 Diabetes. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 William Butler,Christina C Pierre,Bruce E King,Brian Young
-
Congenital Syphilis: An Emerging, Preventable Public Health Crisis. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Fnu Sapna,Kayode Balogun
-
Commentary on Milky Urine in a Patient with Poorly Controlled Type II Diabetes. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 D Jane Hata,Jonathan B Hoyne
-
Methylation-Associated Nucleosomal Patterns of Cell-Free DNA in Cancer Patients and Pregnant Women Clin. Chem. (IF 7.1) Pub Date : 2024-08-29 Guanhua Zhu, Peiyong Jiang, Xingqian Li, Wenlei Peng, L Y Lois Choy, Stephanie C Y Yu, Qing Zhou, Mary-Jane L Ma, Guannan Kang, Jinyue Bai, Rong Qiao, Chian Xi Shirley Deng, Spencer C Ding, Wai Kei Jacky Lam, Stephen L Chan, So Ling Lau, Tak Y Leung, John Wong, K C Allen Chan, Y M Dennis Lo
Background Cell-free DNA (cfDNA) analysis offers an attractive noninvasive means of detecting and monitoring diseases. cfDNA cleavage patterns within a short range (e.g., 11 nucleotides) have been reported to correlate with cytosine-phosphate-guanine (CpG) methylation, allowing fragmentomics-based methylation analysis (FRAGMA). Here, we adopted FRAGMA to the extended region harboring multiple nucleosomes
-
Comparison of 2 Free Light Chain Assays: Performance of the Free Light Chain Ratio as a Risk Factor for MGUS Progression Clin. Chem. (IF 7.1) Pub Date : 2024-08-29 Qian Wang, Benjamin D Andress, Vanessa M K Pazdernik, Dirk R Larson, Jonathan D Coker, Surendra Dasari, Vincent Rajkumar, Angela Dispenzieri, David L Murray, Maria Alice V Willrich
Background New immunoglobulin free light chain (FLC) assays are available. Despite analytical differences, it seems possible to use free light chain ratios (FLCr) generated by different assays and apply similar cut-points for the diagnosis of multiple myeloma. It is still unknown if we can use different assays for risk stratification of patients with monoclonal gammopathy of undetermined significance
-
Extent of Equivalence of Results for Urine Albumin among 3 Candidate Mass Spectrometry Reference Measurement Procedures Clin. Chem. (IF 7.1) Pub Date : 2024-08-29 W Greg Miller, Lorin M Bachmann, Jeffrey Budd, Ashley Beasley-Green, Karen W Phinney, Hwee Tong Tan, Tang Lin Teo, Qinde Liu, Seiei Shiba, Jesse Seegmiller
Background Urine albumin (UA) is an important biomarker of chronic kidney disease. Current in vitro diagnostic medical devices (IVD-MDs) for measuring UA are not standardized, and median results among IVD-MDs differ by approximately 45%. Since fixed decision values are used to interpret UA, higher-order reference measurement procedures (RMPs) are needed for metrological traceability. Three candidate
-
Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism Clin. Chem. (IF 7.1) Pub Date : 2024-08-29 Seul Kee Byeon, Jinyong Kim, Peter Jared Wegwerth, Roman Zenka, John P George, Filippo Pinto e Vairo, Devin Oglesbee, Matthew J Schultz, Dietrich Matern, Akhilesh Pandey
Background Sphingolipids play a crucial role in cellular functions and are essential components of cell membranes, signaling molecules, and lipid metabolism. In particular, ceramide is a key intermediate in sphingolipid metabolism and defects in ceramide metabolism can lead to various inborn errors of metabolism, making ceramides important targets for clinical screening and diagnosis. Detecting altered
-
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes-Does It Matter? Clin. Chem. (IF 7.1) Pub Date : 2024-08-26 Ziwen Li,Jasper Boeddinghaus,Nicholas L Mills
-
Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data Clin. Chem. (IF 7.1) Pub Date : 2024-08-26 Abdurrahman Coşkun, Sverre Sandberg, Ibrahim Unsal, Deniz I Topcu, Aasne K Aarsand
Background Conventional population-based reference intervals (popRIs) are established on the ranking of single measurement results from at least 120 reference individuals. In this study, we aimed to explore a new model for popRIs, utilizing biological variation (BV) data to define the reference interval (RI) limits and compared BV-based popRI from different sample sizes with previously published conventional
-
Machine Learning-Based Sample Misidentification Error Detection in Clinical Laboratory Tests: A Retrospective Multicenter Study Clin. Chem. (IF 7.1) Pub Date : 2024-08-22 Hyeon Seok Seok, Shinae Yu, Kyung-Hwa Shin, Woochang Lee, Sail Chun, Sollip Kim, Hangsik Shin
Background In clinical laboratories, the precision and sensitivity of autoverification technologies are crucial for ensuring reliable diagnostics. Conventional methods have limited sensitivity and applicability, making error detection challenging and reducing laboratory efficiency. This study introduces a machine learning (ML)-based autoverification technology to enhance tumor marker test error detection
-
Failure of Serum Immunofixation Electrophoresis to Detect Intact Monoclonal IgD Lambda Unraveled by Mass Spectrometry. Clin. Chem. (IF 7.1) Pub Date : 2024-08-20 Louis Nevejan,Mark Perkins,Martine Vercammen,Thibault Vanhove,Michel Delforge,Xavier Bossuyt
-
Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I Clin. Chem. (IF 7.1) Pub Date : 2024-08-09 Nasir Saeed, Ole-Thomas Steiro, Jørund Langørgen, Hilde L Tjora, Rune O Bjørneklett, Øyvind Skadberg, Vernon V S Bonarjee, Øistein R Mjelva, Tone M Norekvål, Trude Steinsvik, Kjell Vikenes, Torbjørn Omland, Kristin M Aakre
Background There are limited data regarding the utility of follow-up cardiac troponin (cTn) measurements after admission for acute chest pain and how long-term stability of myocardial injury and prognostic value differ when using cardiac troponin T (cTnT) or I (cTnI). Methods We measured high-sensitivity (hs)-cTnT (Roche Diagnostics) and hs-cTnI (Siemens Healthineers) during hospitalization for acute
-
Implications of Age for the Diagnostic and Prognostic Value of Cardiac Troponin T and I Clin. Chem. (IF 7.1) Pub Date : 2024-08-09 Rasmus Bo Hasselbalch, Philip Andreas Schytz, Martin Schultz, Caroline Sindet-Pedersen, Jonas Henrik Kristensen, Nina Strandkjær, Sophie Sander Knudsen, Mia Pries-Heje, Manan Pareek, Kristian H Kragholm, Nicholas Carlson, Morten Schou, Mikkel Porsborg Andersen, Henning Bundgaard, Christian Torp-Pedersen, Kasper Karmark Iversen
Background The influence of age on cardiac troponin is unclear and may vary between cardiac troponin T (cTnT) and I (cTnI). We aimed to compare the impact of age on the diagnostic and prognostic utility of cTnT and cTnI. Methods This Danish nationwide, register-based cohort study included patients with at least one cardiac troponin (cTn) measurement from 2009 through June 2022, stratified into decades
-
Laboratory Testing for Celiac Disease: Clinical and Methodological Considerations Clin. Chem. (IF 7.1) Pub Date : 2024-08-05 Steffen Husby, Rok Seon Choung, Cæcilie Crawley, Søren T Lillevang, Joseph A Murray
Background Celiac disease (CeD) has an estimated prevalence of 1%–3%. The classical clinical presentation is malabsorption, but now patients may present with more subtle symptoms such as constipation, osteoporosis, or iron deficiency anemia. Children may also present with poor growth. CeD has a strong genetic component, and high-risk groups include first-degree relatives with CeD, patients with co-existing
-
Clinical Utility of LC-MS/MS for Blood Myo-Inositol in Patients with Acute Kidney Injury and Chronic Kidney Disease. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Catherine L Omosule,Connor J Blair,Elizabeth Herries,Mark A Zaydman,Christopher Farnsworth,Jack Ladenson,Dennis J Dietzen,Joseph P Gaut
BACKGROUND Diagnosing acute kidney injury (AKI) and chronic kidney disease (CKD) relies on creatinine, which lacks optimal diagnostic sensitivity. The kidney-specific proximal tubular enzyme myo-inositol oxygenase (MIOX) catalyzes the conversion of myo-inositol (MI) to D-glucuronic acid. We hypothesized that proximal tubular damage, which occurs in AKI and CKD, will decrease MIOX activity, causing
-
Inconsistent Hb A1c Results Observed after Implementing a New Method. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Song Lu,Terri Neibauer,Eric Saylor,Bonifacio Dewasse,Yusheng Zhu
-
Commentary on Inconsistent Hb A1c Results Observed after Implementing a New Method. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Cas W Weykamp,Carla W Siebelder
-
Clinical Laboratories Confront a New Wave of Drug Overdose Deaths. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Adina Badea
-
Improving Health for Our Aging Population. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Hanna S Loving
-
Commentary on Inconsistent Hb A1c Results Observed after Implementing a New Method. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Sean T Campbell
-
Beyond the Screen: Navigating Remote Work within Medicine. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Anna E Merrill,Sarah A Hackenmueller,Colin Derdeyn,Jonathan Genzen,Damien Gruson,Melissa Ludgate,Surabhi Mulchandani,M Laura Parnas,Erik Ranheim
-
Detection of DNA Contamination in Prenatal Samples from Whole Exome Sequencing Data. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Sanne P Smeekens,Raoul Timmermans,Dineke Westra,Christian Gilissen,Brigitte H W Faas
BACKGROUND Maternal cell contamination (MCC) in prenatal samples poses a risk for misdiagnosis, and therefore, testing for contamination is necessary during genetic analysis of prenatal specimens. MCC testing is currently performed as a method separate from the diagnostic method. With the increasing application of whole exome sequencing (WES) in prenatal diagnosis, we sought to develop a method to
-
Analysis of Troponin Fragments: The Start of a New Era-Perhaps? Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Allan S Jaffe
-
Machine Learning-Based Prediction of Hemoglobinopathies Using Complete Blood Count Data. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Anoeska Schipper,Matthieu Rutten,Adriaan van Gammeren,Cornelis L Harteveld,Eloísa Urrechaga,Floor Weerkamp,Gijs den Besten,Johannes Krabbe,Jennichjen Slomp,Lise Schoonen,Maarten Broeren,Merel van Wijnen,Mirelle J A J Huijskens,Tamara Koopmann,Bram van Ginneken,Ron Kusters,Steef Kurstjens
BACKGROUND Hemoglobinopathies, the most common inherited blood disorder, are frequently underdiagnosed. Early identification of carriers is important for genetic counseling of couples at risk. The aim of this study was to develop and validate a novel machine learning model on a multicenter data set, covering a wide spectrum of hemoglobinopathies based on routine complete blood count (CBC) testing.
-
Highly Sensitive Immunoassay for Long Forms of Cardiac Troponin T Using Upconversion Luminescence. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Selma M Salonen,Tuulia J K Tuominen,Kirsti I S Raiko,Tuija Vasankari,Rami Aalto,Tapio A Hellman,Satu E Lahtinen,Tero Soukka,K E Juhani Airaksinen,Saara T Wittfooth
BACKGROUND Long cardiac troponin T (cTnT) has been proposed to be a promising and more specific biomarker of acute myocardial infarction (AMI). As it represents a subfraction of circulating cTnT, detection of very low concentrations is a requirement. The aim of this study was to develop a novel, highly sensitive immunoassay for long cTnT. METHODS A two-step sandwich-type immunoassay for long cTnT was
-
Blood Biomarkers for the Management of Mild Traumatic Brain Injury in Clinical Practice. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Charlotte Oris,Samy Kahouadji,Damien Bouvier,Vincent Sapin
BACKGROUND Despite the use of validated guidelines in the management of mild traumatic brain injury (mTBI), processes to limit unnecessary brain scans are still not sufficient and need to be improved. The use of blood biomarkers represents a relevant adjunct to identify patients at risk for intracranial injury requiring computed tomography (CT) scan. CONTENT Biomarkers currently recommended in the
-
Correction to: Applying Machine Learning to Blood Count Data Predicts Sepsis with ICU Admission. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01
-
Nanopore Protein Sequencing Achieves Significant New Milestones. Clin. Chem. (IF 7.1) Pub Date : 2024-08-01 Brian C Searle
-
ChatGPT: A Reliable Laboratory Medicine Consult? Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Joe M El-Khoury
-
Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Fangyan Yu,Farzana Ahmed,Stavroula Smilkou,Sayeda Yasmin-Karim,Farzaneh Darbeheshti,Athina Markou,Martyn Bullock,Ioannis Boukovinas,Viktor A Adalsteinsson,Evi Lianidou,G Mike Makrigiorgos
BACKGROUND Detection of minor DNA allele alterations is becoming increasingly important for early detection and monitoring of cancer. We describe a new method that uses ultraviolet light to eliminate wild-type DNA alleles and enables improved detection of minor genetic or epigenetic changes. METHODS Pyrimidine-dependent UV-based minor-allele enrichment (PD-UVME) employed oligonucleotide probes that
-
Correction to: High Lead Levels in 2 Independent and Authenticated Locks of Beethoven's Hair. Clin. Chem. (IF 7.1) Pub Date : 2024-07-18
-
Is Long COVID a Complement Dysregulation Disease? Clin. Chem. (IF 7.1) Pub Date : 2024-07-16 Wioleta M Zelek
-
ChatGPT vs Medical Professional: Analyzing Responses to Laboratory Medicine Questions on Social Media Clin. Chem. (IF 7.1) Pub Date : 2024-07-16 Mark R Girton, Dina N Greene, Geralyn Messerlian, David F Keren, Min Yu
Background The integration of ChatGPT, a large language model (LLM) developed by OpenAI, into healthcare has sparked significant interest due to its potential to enhance patient care and medical education. With the increasing trend of patients accessing laboratory results online, there is a pressing need to evaluate the effectiveness of ChatGPT in providing accurate laboratory medicine information
-
The Era of Early Detection and Treatment of Brain Amyloid Deposition in Asymptomatic Individuals? Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Danni Li,William G Mantyh
-
Problematic Proteins: A Patient with a High Paraprotein Concentration. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Glen L Hortin,Robert T Stapp,Shrinjaya B Thapa,Ariel F Grajales-Cruz
-
Breaking Boundaries: Exploring Performance Enhancement and Anti-Doping Testing in Sports. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Imir G Metushi,Allison Wagner,Brian Ahrens,Magnus Ericsson,Olivier Rabin,Tim Sobolevsky,Travis T Tygart
-
Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Geralyn Messerlian,Sydney Webb Strickland,Jordan Willbur,Christine Vaughan,Shelby Koenig,Taylor Wright,Glenn E Palomaki
BACKGROUND Maternal serum alpha-fetoprotein (AFP) levels are used in screening for open neural tube defects (ONTD). Historical reports show that AFP levels and maternal weights are higher in self-reported Black than White individuals, but recent reports question the need to account for these variables in screening. Our study compares screening performance with and without accounting for race. METHODS
-
Commentary on Problematic Proteins: A Case with High Paraprotein Concentration. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Sarah M Schrader
-
Commentary on Problematic Proteins: A Case with High Paraprotein Concentration. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Louis Nevejan,Xavier Bossuyt
-
Joint Consensus Recommendations for Validating Cell-Free DNA Assays. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Nicholas E Larkey,Vera A Paulson
-
The Inclusion of Race in Prenatal Screening Algorithms. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Mary E Norton,Neil Risch
-
Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Shinji Koba,Noriyuki Satoh,Yasuki Ito,Yuya Yokota,Fumiyoshi Tsunoda,Koshiro Sakai,Yuya Nakamura,Makoto Shoji,Tsutomu Hirano,Toshiro Shinke
BACKGROUND This study investigated whether directly measured small dense low-density lipoprotein cholesterol (D-sdLDL-C) can predict long-term coronary artery disease (CAD) events compared with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B (apoB), and estimated small dense low-density lipoprotein cholesterol (E-sdLDL-C) determined
-
Epigenetic Leukocyte Counts from Dried Blood Spots of Pediatric Patients. Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Wouter Hubens,Lara Kluge,Alexander Seitz,Eva Verjans,Lothar Rink,Wolfgang Wagner
-
Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter? Clin. Chem. (IF 7.1) Pub Date : 2024-07-05 Supawadee Suppadungsuk,Kianoush Kashani
-
Atypical Interference in Hb A1c Measurements Might Be Due to Mosaic Expression of Hemoglobin Variants. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Annelie Strålfors,Kristina Lagerstedt-Robinson,Britta Landin
-
Data Mining Reference Intervals by ICD-10 Stratified Differential Distributions. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Tobias U Blatter,David Schär,Harald Witte,Christos T Nakas,Alexander B Leichtle
-
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies—Information Everybody Wants but Nobody Wants to Pay For Clin. Chem. (IF 7.1) Pub Date : 2024-07-03 Lilli Bonstingl, Christina Skofler, Christine Ulz, Margret Zinnegger, Katja Sallinger, Julia Schönberger, Katharina Schuch, Karin Pankratz, Anatol Borrás-Cherrier, Visnja Somodi, Peter M Abuja, Lisa Oberauner-Wappis, Tina Moser, Ellen Heitzer, Thomas Bauernhofer, Thomas Kroneis, Amin El-Heliebi
Background Liquid biopsies are emerging as valuable clinical biomarkers for cancer monitoring. Although International Organization for Standards (ISO) and Technical Specifications from the European Committee for Standardization (CEN/TS) standardized workflows exist, their implementation in clinical practice is underdeveloped. We aimed to assess the applicability of ISO and CEN/TS standards in a real-world
-
Association of Serum Trimethylamine-N-Oxide Concentration from Childhood to Early Adulthood with Age and Sex. Clin. Chem. (IF 7.1) Pub Date : 2024-09-03 Gunter Almer,Dietmar Enko,Noora Kartiosuo,Harri Niinikoski,Terho Lehtimäki,Eveliina Munukka,Jorma Viikari,Tapani Rönnemaa,Suvi P Rovio,Juha Mykkänen,Hanna Lagström,Antti Jula,Markus Herrmann,Olli T Raitakari,Andreas Meinitzer,Katja Pahkala
BACKGROUND Primary prevention is the cornerstone of cardiometabolic health. In the randomized, controlled Special Turku Coronary Risk Factor Intervention Project (STRIP), dietary counseling intervention was given to children from infancy to 20 years of age and a follow-up was completed at age 26 years. We investigated the associations of age, sex, gut microbiome, and dietary intervention with the gut
-
Universal Targeted Haplotyping by Droplet Digital PCR Sequencing and Its Applications in Noninvasive Prenatal Testing and Pharmacogenetics Analysis Clin. Chem. (IF 7.1) Pub Date : 2024-06-14 Wanxia Gai, Guangya Wang, W K Jacky Lam, Liz Y P Yuen, Peiyong Jiang, Stephanie C Y Yu, Tak Y Leung, So Ling Lau, Y M Dennis Lo, K C Allen Chan
Background The analysis of haplotypes of variants is important for pharmacogenomics analysis and noninvasive prenatal testing for monogenic diseases. However, there is a lack of robust methods for targeted haplotyping. Methods We developed digital PCR haplotype sequencing (dHapSeq) for targeted haplotyping of variants, which is a method that compartmentalizes long DNA molecules into droplets. Within
-
Autism Spectrum Disorder and Mild Developmental Delay in a Patient with a Rare Inborn Error of Metabolism. Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Irene De Biase,Karl de Dios,Stephen A Brose,Judith A Hobert
-
Y Chromosome: The Dark Matter of the Human Genome Unveiled. Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Shivaprasad H Sathyanarayana,Madhumala K Sadanandappa,Joel A Lefferts
-
Study Highlights Difficulties in the Diagnosis of Myelodysplastic Neoplasms (MDS). Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Mark R Girton
-
Microbiome-Based Diagnostics for Disease: Where Are We Now and Where Are We Headed? Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Melanie L Yarbrough,Rebekah E Dumm,Lynn Bry,Brendan J Kelly,Drew Schwartz,Aayushi Uberoi
-
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology. Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Etienne Cavalier,Jean-Claude Souberbielle
-
Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology. Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Umair Sajid,Dennis Orton,Martin Kaufmann,Glenville Jones,Gregory A Kline
-
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology. Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Paul K Hamilton
-
Optical Genome Mapping in Prenatal Diagnosis: Democratizing Comprehensive Cytogenomic Testing. Clin. Chem. (IF 7.1) Pub Date : 2024-06-03 Mariam T Mathew,Yassmine M N Akkari